NasdaqGS - Nasdaq Real Time Price USD
Allogene Therapeutics, Inc. (ALLO)
1.0900
-0.0200
(-1.80%)
At close: 4:00:01 PM EDT
1.0900
0.00
(0.00%)
After hours: 4:02:06 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 10 | 10 | 10 | 9 |
| Avg. Estimate | -0.26 | -0.25 | -1.01 | -0.97 |
| Low Estimate | -0.3 | -0.29 | -1.2 | -1.47 |
| High Estimate | -0.21 | -0.19 | -0.74 | -0.55 |
| Year Ago EPS | -0.32 | -0.27 | -1.24 | -1.01 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 12 | 12 | 12 | 11 |
| Avg. Estimate | 1.67k | 1.67k | 5k | 16.36k |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | 20k | 20k | 60k | 100k |
| Year Ago Sales | -- | -- | 22k | 5k |
| Sales Growth (year/est) | 0.00% | 0.00% | -77.27% | 227.20% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.35 | -0.33 | -0.32 | -0.29 |
| EPS Actual | -0.32 | -0.27 | -0.28 | -0.28 |
| Difference | 0.03 | 0.06 | 0.04 | 0.01 |
| Surprise % | 7.60% | 19.52% | 13.43% | 5.08% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.26 | -0.25 | -1.01 | -0.97 |
| 7 Days Ago | -0.27 | -0.28 | -1.2 | -1.37 |
| 30 Days Ago | -0.26 | -0.27 | -1.12 | -1.32 |
| 60 Days Ago | -0.27 | -0.27 | -1.13 | -1.28 |
| 90 Days Ago | -0.34 | -0.34 | -1.37 | -1.45 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | -- | 5 | 3 |
| Up Last 30 Days | 1 | 3 | 5 | -- |
| Down Last 7 Days | 1 | 1 | -- | -- |
| Down Last 30 Days | 1 | -- | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ALLO | 17.94% | 7.68% | 18.89% | 3.90% |
| S&P 500 | 13.32% | 2.67% | 7.78% | 13.75% |
Upgrades & Downgrades
| Maintains | Citigroup: Buy to Buy | 5/15/2025 |
| Maintains | Truist Securities: Buy to Buy | 5/14/2025 |
| Maintains | Piper Sandler: Overweight to Overweight | 5/14/2025 |
| Reiterates | RBC Capital: Outperform to Outperform | 5/14/2025 |
| Maintains | Oppenheimer: Outperform to Outperform | 5/14/2025 |
| Maintains | Baird: Outperform to Outperform | 5/14/2025 |
Related Tickers
FATE Fate Therapeutics, Inc.
1.2200
+14.02%
IOVA Iovance Biotherapeutics, Inc.
1.8300
+10.24%
EDIT Editas Medicine, Inc.
1.4900
-1.32%
CRBU Caribou Biosciences, Inc.
1.0500
+11.89%
SGMO Sangamo Therapeutics, Inc.
0.4985
+6.06%
ATRA Atara Biotherapeutics, Inc.
6.73
-1.61%
SANA Sana Biotechnology, Inc.
1.6800
-3.72%
CTMX CytomX Therapeutics, Inc.
2.1300
+4.93%
AUTL Autolus Therapeutics plc
1.4800
+11.28%
MRSN Mersana Therapeutics, Inc.
0.3850
+13.20%